Institutional Ownership Aligos Therapeutics, Inc. (ALGS)
This table provides information about the institutional ownership of Aligos Therapeutics, Inc. (ALGS). We have compiled data on the 52 institutions that hold shares in the stock, with a total of 47.3 Million shares, which have been reported (via 13F filing form) to have a value of $388 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Armistice Capital, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
7,256,410
shares
|
$59.5 Million
0.03% of portfolio
|
Q2 2024
Added 5.27%
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
6,389,468
shares
|
$52.4 Million
0.08% of portfolio
|
Q4 2023
Added 61.83%
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
6,102,770
shares
|
$50 Million
0.07% of portfolio
|
Q4 2023
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2024 Q2 2024 |
5,000,000
shares
|
$41 Million
0.0% of portfolio
|
Q2 2024
Added 102.88%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 14, 2024 Q2 2024 |
3,547,030
shares
|
$29.1 Million
0.18% of portfolio
|
Q4 2020
New holding
|
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
Aug 14, 2024 Q2 2024 |
3,121,689
shares
|
$25.6 Million
0.03% of portfolio
|
Q2 2024
Added 63.77%
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2024 Q2 2024 |
2,076,400
shares
|
$17 Million
0.01% of portfolio
|
Q3 2021
Added 28.97%
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2024 Q2 2024 |
1,650,000
shares
|
$13.5 Million
0.07% of portfolio
|
Q1 2024
Reduced 24.65%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
1,595,359
shares
|
$13.1 Million
0.0% of portfolio
|
Q2 2024
Added 57.48%
|
|
Versant Venture Management, LLC
San Francisco, CA |
Aug 07, 2024 Q2 2024 |
1,457,937
shares
|
$12 Million
1.13% of portfolio
|
Q2 2024
Reduced 37.17%
|
|
Opaleye Management Inc.
Boston, MA |
Aug 14, 2024 Q2 2024 |
1,260,000
shares
|
$10.3 Million
0.11% of portfolio
|
Q2 2024
Reduced 22.7%
|
|
Ubs Oconnor LLC
Chicago, IL |
Aug 14, 2024 Q2 2024 |
1,000,000
shares
|
$8.2 Million
0.02% of portfolio
|
Q2 2024
Added 100.0%
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 06, 2024 Q2 2024 |
829,485
shares
|
$6.8 Million
0.0% of portfolio
|
Q2 2024
Added 26.06%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2024 Q2 2024 |
816,029
shares
|
$6.69 Million
0.0% of portfolio
|
Q2 2024
Reduced 28.9%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
768,839
shares
|
$6.3 Million
0.0% of portfolio
|
Q2 2024
Reduced 4.88%
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Aug 13, 2024 Q2 2024 |
743,215
shares
|
$6.09 Million
0.23% of portfolio
|
Q2 2022
Reduced 15.21%
|
|
Newtyn Management, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
719,287
shares
|
$5.9 Million
0.05% of portfolio
|
Q2 2024
Reduced 40.06%
|
|
Silverarc Capital Management, LLC
|
Aug 14, 2024 Q2 2024 |
655,515
shares
|
$5.38 Million
0.06% of portfolio
|
Q1 2024
Reduced 1.94%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
531,204
shares
|
$4.36 Million
0.0% of portfolio
|
Q2 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
405,694
shares
|
$3.33 Million
0.0% of portfolio
|
Q2 2024
Added 8.75%
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Aug 14, 2024 Q2 2024 |
284,233
shares
|
$2.33 Million
0.0% of portfolio
|
Q2 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
277,363
shares
|
$2.27 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.91%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
227,406
shares
|
$1.86 Million
0.0% of portfolio
|
Q2 2024
Reduced 25.14%
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
107,123
shares
|
$878,408
0.0% of portfolio
|
Q2 2024
Added 9.96%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
91,950
shares
|
$753,989
0.0% of portfolio
|
Q2 2024
Reduced 0.07%
|